Global Tumor Immunotherapy Market Growth (Status and Outlook) 2023-2028

Report ID: 1479577 | Published Date: Oct 2024 | No. of Page: 123 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Tumor Immunotherapy Market Size 2017-2028
        2.1.2 Tumor Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Tumor Immunotherapy Segment by Type
        2.2.1 Tumor Infiltrating Lymphocyte (TIL) Treatment
        2.2.2 Engineered T Cell Receptor (TCR) Therapy
        2.2.3 Chimeric Antigen Receptor (CAR) T Cell Therapy
        2.2.4 Natural Killer (NK) Cell Therapy
        2.2.5 Other
    2.3 Tumor Immunotherapy Market Size by Type
        2.3.1 Tumor Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Tumor Immunotherapy Market Size Market Share by Type (2017-2022)
    2.4 Tumor Immunotherapy Segment by Application
        2.4.1 Biopharmaceutical Company
        2.4.2 Hospital
        2.4.3 Universities And Other Scientific Research Institutions
        2.4.4 Other
    2.5 Tumor Immunotherapy Market Size by Application
        2.5.1 Tumor Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Tumor Immunotherapy Market Size Market Share by Application (2017-2022)
3 Tumor Immunotherapy Market Size by Player
    3.1 Tumor Immunotherapy Market Size Market Share by Players
        3.1.1 Global Tumor Immunotherapy Revenue by Players (2020-2022)
        3.1.2 Global Tumor Immunotherapy Revenue Market Share by Players (2020-2022)
    3.2 Global Tumor Immunotherapy Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Tumor Immunotherapy by Regions
    4.1 Tumor Immunotherapy Market Size by Regions (2017-2022)
    4.2 Americas Tumor Immunotherapy Market Size Growth (2017-2022)
    4.3 APAC Tumor Immunotherapy Market Size Growth (2017-2022)
    4.4 Europe Tumor Immunotherapy Market Size Growth (2017-2022)
    4.5 Middle East & Africa Tumor Immunotherapy Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Tumor Immunotherapy Market Size by Country (2017-2022)
    5.2 Americas Tumor Immunotherapy Market Size by Type (2017-2022)
    5.3 Americas Tumor Immunotherapy Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Tumor Immunotherapy Market Size by Region (2017-2022)
    6.2 APAC Tumor Immunotherapy Market Size by Type (2017-2022)
    6.3 APAC Tumor Immunotherapy Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Tumor Immunotherapy by Country (2017-2022)
    7.2 Europe Tumor Immunotherapy Market Size by Type (2017-2022)
    7.3 Europe Tumor Immunotherapy Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Tumor Immunotherapy by Region (2017-2022)
    8.2 Middle East & Africa Tumor Immunotherapy Market Size by Type (2017-2022)
    8.3 Middle East & Africa Tumor Immunotherapy Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Tumor Immunotherapy Market Forecast
    10.1 Global Tumor Immunotherapy Forecast by Regions (2023-2028)
        10.1.1 Global Tumor Immunotherapy Forecast by Regions (2023-2028)
        10.1.2 Americas Tumor Immunotherapy Forecast
        10.1.3 APAC Tumor Immunotherapy Forecast
        10.1.4 Europe Tumor Immunotherapy Forecast
        10.1.5 Middle East & Africa Tumor Immunotherapy Forecast
    10.2 Americas Tumor Immunotherapy Forecast by Country (2023-2028)
        10.2.1 United States Tumor Immunotherapy Market Forecast
        10.2.2 Canada Tumor Immunotherapy Market Forecast
        10.2.3 Mexico Tumor Immunotherapy Market Forecast
        10.2.4 Brazil Tumor Immunotherapy Market Forecast
    10.3 APAC Tumor Immunotherapy Forecast by Region (2023-2028)
        10.3.1 China Tumor Immunotherapy Market Forecast
        10.3.2 Japan Tumor Immunotherapy Market Forecast
        10.3.3 Korea Tumor Immunotherapy Market Forecast
        10.3.4 Southeast Asia Tumor Immunotherapy Market Forecast
        10.3.5 India Tumor Immunotherapy Market Forecast
        10.3.6 Australia Tumor Immunotherapy Market Forecast
    10.4 Europe Tumor Immunotherapy Forecast by Country (2023-2028)
        10.4.1 Germany Tumor Immunotherapy Market Forecast
        10.4.2 France Tumor Immunotherapy Market Forecast
        10.4.3 UK Tumor Immunotherapy Market Forecast
        10.4.4 Italy Tumor Immunotherapy Market Forecast
        10.4.5 Russia Tumor Immunotherapy Market Forecast
    10.5 Middle East & Africa Tumor Immunotherapy Forecast by Region (2023-2028)
        10.5.1 Egypt Tumor Immunotherapy Market Forecast
        10.5.2 South Africa Tumor Immunotherapy Market Forecast
        10.5.3 Israel Tumor Immunotherapy Market Forecast
        10.5.4 Turkey Tumor Immunotherapy Market Forecast
        10.5.5 GCC Countries Tumor Immunotherapy Market Forecast
    10.6 Global Tumor Immunotherapy Forecast by Type (2023-2028)
    10.7 Global Tumor Immunotherapy Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Roche
        11.1.1 Roche Company Information
        11.1.2 Roche Tumor Immunotherapy Product Offered
        11.1.3 Roche Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Roche Main Business Overview
        11.1.5 Roche Latest Developments
    11.2 Merck
        11.2.1 Merck Company Information
        11.2.2 Merck Tumor Immunotherapy Product Offered
        11.2.3 Merck Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Merck Main Business Overview
        11.2.5 Merck Latest Developments
    11.3 Novartis
        11.3.1 Novartis Company Information
        11.3.2 Novartis Tumor Immunotherapy Product Offered
        11.3.3 Novartis Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Novartis Main Business Overview
        11.3.5 Novartis Latest Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Information
        11.4.2 Johnson & Johnson Tumor Immunotherapy Product Offered
        11.4.3 Johnson & Johnson Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Johnson & Johnson Main Business Overview
        11.4.5 Johnson & Johnson Latest Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Information
        11.5.2 GlaxoSmithKline Tumor Immunotherapy Product Offered
        11.5.3 GlaxoSmithKline Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 GlaxoSmithKline Main Business Overview
        11.5.5 GlaxoSmithKline Latest Developments
    11.6 AbbVie
        11.6.1 AbbVie Company Information
        11.6.2 AbbVie Tumor Immunotherapy Product Offered
        11.6.3 AbbVie Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 AbbVie Main Business Overview
        11.6.5 AbbVie Latest Developments
    11.7 ELI Lilly
        11.7.1 ELI Lilly Company Information
        11.7.2 ELI Lilly Tumor Immunotherapy Product Offered
        11.7.3 ELI Lilly Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 ELI Lilly Main Business Overview
        11.7.5 ELI Lilly Latest Developments
    11.8 Amgen
        11.8.1 Amgen Company Information
        11.8.2 Amgen Tumor Immunotherapy Product Offered
        11.8.3 Amgen Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Amgen Main Business Overview
        11.8.5 Amgen Latest Developments
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Information
        11.9.2 AstraZeneca Tumor Immunotherapy Product Offered
        11.9.3 AstraZeneca Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 AstraZeneca Main Business Overview
        11.9.5 AstraZeneca Latest Developments
    11.10 Bristol-Mysers Squibb
        11.10.1 Bristol-Mysers Squibb Company Information
        11.10.2 Bristol-Mysers Squibb Tumor Immunotherapy Product Offered
        11.10.3 Bristol-Mysers Squibb Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Bristol-Mysers Squibb Main Business Overview
        11.10.5 Bristol-Mysers Squibb Latest Developments
    11.11 Kite Pharma
        11.11.1 Kite Pharma Company Information
        11.11.2 Kite Pharma Tumor Immunotherapy Product Offered
        11.11.3 Kite Pharma Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Kite Pharma Main Business Overview
        11.11.5 Kite Pharma Latest Developments
    11.12 Adaptimmune
        11.12.1 Adaptimmune Company Information
        11.12.2 Adaptimmune Tumor Immunotherapy Product Offered
        11.12.3 Adaptimmune Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Adaptimmune Main Business Overview
        11.12.5 Adaptimmune Latest Developments
    11.13 Altor Bioscience Corporation
        11.13.1 Altor Bioscience Corporation Company Information
        11.13.2 Altor Bioscience Corporation Tumor Immunotherapy Product Offered
        11.13.3 Altor Bioscience Corporation Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Altor Bioscience Corporation Main Business Overview
        11.13.5 Altor Bioscience Corporation Latest Developments
    11.14 Cellectis
        11.14.1 Cellectis Company Information
        11.14.2 Cellectis Tumor Immunotherapy Product Offered
        11.14.3 Cellectis Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Cellectis Main Business Overview
        11.14.5 Cellectis Latest Developments
    11.15 Juno Therapeutics
        11.15.1 Juno Therapeutics Company Information
        11.15.2 Juno Therapeutics Tumor Immunotherapy Product Offered
        11.15.3 Juno Therapeutics Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Juno Therapeutics Main Business Overview
        11.15.5 Juno Therapeutics Latest Developments
    11.16 Takara Bio
        11.16.1 Takara Bio Company Information
        11.16.2 Takara Bio Tumor Immunotherapy Product Offered
        11.16.3 Takara Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Takara Bio Main Business Overview
        11.16.5 Takara Bio Latest Developments
    11.17 Unum Therapeutics
        11.17.1 Unum Therapeutics Company Information
        11.17.2 Unum Therapeutics Tumor Immunotherapy Product Offered
        11.17.3 Unum Therapeutics Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Unum Therapeutics Main Business Overview
        11.17.5 Unum Therapeutics Latest Developments
    11.18 Sunway
        11.18.1 Sunway Company Information
        11.18.2 Sunway Tumor Immunotherapy Product Offered
        11.18.3 Sunway Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 Sunway Main Business Overview
        11.18.5 Sunway Latest Developments
    11.19 Junshi Bio
        11.19.1 Junshi Bio Company Information
        11.19.2 Junshi Bio Tumor Immunotherapy Product Offered
        11.19.3 Junshi Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 Junshi Bio Main Business Overview
        11.19.5 Junshi Bio Latest Developments
    11.20 Cinda Bio
        11.20.1 Cinda Bio Company Information
        11.20.2 Cinda Bio Tumor Immunotherapy Product Offered
        11.20.3 Cinda Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.20.4 Cinda Bio Main Business Overview
        11.20.5 Cinda Bio Latest Developments
    11.21 BeiGene
        11.21.1 BeiGene Company Information
        11.21.2 BeiGene Tumor Immunotherapy Product Offered
        11.21.3 BeiGene Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
        11.21.4 BeiGene Main Business Overview
        11.21.5 BeiGene Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Tumor Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Tumor Infiltrating Lymphocyte (TIL) Treatment
    Table 3. Major Players of Engineered T Cell Receptor (TCR) Therapy
    Table 4. Major Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
    Table 5. Major Players of Natural Killer (NK) Cell Therapy
    Table 6. Major Players of Other
    Table 7. Tumor Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Tumor Immunotherapy Market Size Market Share by Type (2017-2022)
    Table 10. Tumor Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Tumor Immunotherapy Market Size Market Share by Application (2017-2022)
    Table 13. Global Tumor Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Tumor Immunotherapy Revenue Market Share by Player (2020-2022)
    Table 15. Tumor Immunotherapy Key Players Head office and Products Offered
    Table 16. Tumor Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Tumor Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Tumor Immunotherapy Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Tumor Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Tumor Immunotherapy Market Size Market Share by Country (2017-2022)
    Table 23. Americas Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Tumor Immunotherapy Market Size Market Share by Type (2017-2022)
    Table 25. Americas Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Tumor Immunotherapy Market Size Market Share by Application (2017-2022)
    Table 27. APAC Tumor Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Tumor Immunotherapy Market Size Market Share by Region (2017-2022)
    Table 29. APAC Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Tumor Immunotherapy Market Size Market Share by Type (2017-2022)
    Table 31. APAC Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Tumor Immunotherapy Market Size Market Share by Application (2017-2022)
    Table 33. Europe Tumor Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Tumor Immunotherapy Market Size Market Share by Country (2017-2022)
    Table 35. Europe Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Tumor Immunotherapy Market Size Market Share by Type (2017-2022)
    Table 37. Europe Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Tumor Immunotherapy Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Tumor Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Tumor Immunotherapy
    Table 46. Key Market Challenges & Risks of Tumor Immunotherapy
    Table 47. Key Industry Trends of Tumor Immunotherapy
    Table 48. Global Tumor Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Tumor Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Tumor Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Tumor Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Tumor Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Tumor Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Roche Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 55. Roche Tumor Immunotherapy Product Offered
    Table 56. Roche Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Roche Main Business
    Table 58. Roche Latest Developments
    Table 59. Merck Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 60. Merck Tumor Immunotherapy Product Offered
    Table 61. Merck Main Business
    Table 62. Merck Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Merck Latest Developments
    Table 64. Novartis Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 65. Novartis Tumor Immunotherapy Product Offered
    Table 66. Novartis Main Business
    Table 67. Novartis Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. Novartis Latest Developments
    Table 69. Johnson & Johnson Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 70. Johnson & Johnson Tumor Immunotherapy Product Offered
    Table 71. Johnson & Johnson Main Business
    Table 72. Johnson & Johnson Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. Johnson & Johnson Latest Developments
    Table 74. GlaxoSmithKline Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 75. GlaxoSmithKline Tumor Immunotherapy Product Offered
    Table 76. GlaxoSmithKline Main Business
    Table 77. GlaxoSmithKline Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. GlaxoSmithKline Latest Developments
    Table 79. AbbVie Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 80. AbbVie Tumor Immunotherapy Product Offered
    Table 81. AbbVie Main Business
    Table 82. AbbVie Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. AbbVie Latest Developments
    Table 84. ELI Lilly Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 85. ELI Lilly Tumor Immunotherapy Product Offered
    Table 86. ELI Lilly Main Business
    Table 87. ELI Lilly Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. ELI Lilly Latest Developments
    Table 89. Amgen Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 90. Amgen Tumor Immunotherapy Product Offered
    Table 91. Amgen Main Business
    Table 92. Amgen Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Amgen Latest Developments
    Table 94. AstraZeneca Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 95. AstraZeneca Tumor Immunotherapy Product Offered
    Table 96. AstraZeneca Main Business
    Table 97. AstraZeneca Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. AstraZeneca Latest Developments
    Table 99. Bristol-Mysers Squibb Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 100. Bristol-Mysers Squibb Tumor Immunotherapy Product Offered
    Table 101. Bristol-Mysers Squibb Main Business
    Table 102. Bristol-Mysers Squibb Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. Bristol-Mysers Squibb Latest Developments
    Table 104. Kite Pharma Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 105. Kite Pharma Tumor Immunotherapy Product Offered
    Table 106. Kite Pharma Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 107. Kite Pharma Main Business
    Table 108. Kite Pharma Latest Developments
    Table 109. Adaptimmune Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 110. Adaptimmune Tumor Immunotherapy Product Offered
    Table 111. Adaptimmune Main Business
    Table 112. Adaptimmune Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 113. Adaptimmune Latest Developments
    Table 114. Altor Bioscience Corporation Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 115. Altor Bioscience Corporation Tumor Immunotherapy Product Offered
    Table 116. Altor Bioscience Corporation Main Business
    Table 117. Altor Bioscience Corporation Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 118. Altor Bioscience Corporation Latest Developments
    Table 119. Cellectis Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 120. Cellectis Tumor Immunotherapy Product Offered
    Table 121. Cellectis Main Business
    Table 122. Cellectis Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 123. Cellectis Latest Developments
    Table 124. Juno Therapeutics Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 125. Juno Therapeutics Tumor Immunotherapy Product Offered
    Table 126. Juno Therapeutics Main Business
    Table 127. Juno Therapeutics Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 128. Juno Therapeutics Latest Developments
    Table 129. Takara Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 130. Takara Bio Tumor Immunotherapy Product Offered
    Table 131. Takara Bio Main Business
    Table 132. Takara Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 133. Takara Bio Latest Developments
    Table 134. Unum Therapeutics Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 135. Unum Therapeutics Tumor Immunotherapy Product Offered
    Table 136. Unum Therapeutics Main Business
    Table 137. Unum Therapeutics Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 138. Unum Therapeutics Latest Developments
    Table 139. Sunway Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 140. Sunway Tumor Immunotherapy Product Offered
    Table 141. Sunway Main Business
    Table 142. Sunway Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 143. Sunway Latest Developments
    Table 144. Junshi Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 145. Junshi Bio Tumor Immunotherapy Product Offered
    Table 146. Junshi Bio Main Business
    Table 147. Junshi Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 148. Junshi Bio Latest Developments
    Table 149. Cinda Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 150. Cinda Bio Tumor Immunotherapy Product Offered
    Table 151. Cinda Bio Main Business
    Table 152. Cinda Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 153. Cinda Bio Latest Developments
    Table 154. BeiGene Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
    Table 155. BeiGene Tumor Immunotherapy Product Offered
    Table 156. BeiGene Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 157. BeiGene Main Business
    Table 158. BeiGene Latest Developments
List of Figures
    Figure 1. Tumor Immunotherapy Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Tumor Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Tumor Immunotherapy Market Size Market Share by Type in 2021
    Figure 7. Tumor Immunotherapy in Biopharmaceutical Company
    Figure 8. Global Tumor Immunotherapy Market: Biopharmaceutical Company (2017-2022) & ($ Millions)
    Figure 9. Tumor Immunotherapy in Hospital
    Figure 10. Global Tumor Immunotherapy Market: Hospital (2017-2022) & ($ Millions)
    Figure 11. Tumor Immunotherapy in Universities And Other Scientific Research Institutions
    Figure 12. Global Tumor Immunotherapy Market: Universities And Other Scientific Research Institutions (2017-2022) & ($ Millions)
    Figure 13. Tumor Immunotherapy in Other
    Figure 14. Global Tumor Immunotherapy Market: Other (2017-2022) & ($ Millions)
    Figure 15. Global Tumor Immunotherapy Market Size Market Share by Application in 2021
    Figure 16. Global Tumor Immunotherapy Revenue Market Share by Player in 2021
    Figure 17. Global Tumor Immunotherapy Market Size Market Share by Regions (2017-2022)
    Figure 18. Americas Tumor Immunotherapy Market Size 2017-2022 ($ Millions)
    Figure 19. APAC Tumor Immunotherapy Market Size 2017-2022 ($ Millions)
    Figure 20. Europe Tumor Immunotherapy Market Size 2017-2022 ($ Millions)
    Figure 21. Middle East & Africa Tumor Immunotherapy Market Size 2017-2022 ($ Millions)
    Figure 22. Americas Tumor Immunotherapy Value Market Share by Country in 2021
    Figure 23. Americas Tumor Immunotherapy Consumption Market Share by Type in 2021
    Figure 24. Americas Tumor Immunotherapy Market Size Market Share by Application in 2021
    Figure 25. United States Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Canada Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 27. Mexico Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Brazil Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 29. APAC Tumor Immunotherapy Market Size Market Share by Region in 2021
    Figure 30. APAC Tumor Immunotherapy Market Size Market Share by Application in 2021
    Figure 31. China Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Japan Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Korea Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Southeast Asia Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 35. India Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Australia Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 37. Europe Tumor Immunotherapy Market Size Market Share by Country in 2021
    Figure 38. Europe Tumor Immunotherapy Market Size Market Share by Type in 2021
    Figure 39. Europe Tumor Immunotherapy Market Size Market Share by Application in 2021
    Figure 40. Germany Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 41. France Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 42. UK Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Italy Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 44. Russia Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Region in 2021
    Figure 46. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Type in 2021
    Figure 47. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Application in 2021
    Figure 48. Egypt Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 49. South Africa Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 50. Israel Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Turkey Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 52. GCC Country Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Americas Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 54. APAC Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 55. Europe Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 56. Middle East & Africa Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 57. United States Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 58. Canada Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 59. Mexico Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 60. Brazil Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 61. China Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 62. Japan Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 63. Korea Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 64. Southeast Asia Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 65. India Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 66. Australia Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 67. Germany Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 68. France Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 69. UK Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 70. Italy Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 71. Russia Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 72. Spain Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 73. Egypt Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 74. South Africa Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 75. Israel Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 76. Turkey Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
    Figure 77. GCC Countries Tumor Immunotherapy Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Tumor Immunotherapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Tumor Immunotherapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Tumor Immunotherapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports